AstraZeneca | Common News Update

Apr22021 by adminNo Comments

Covid-19: Seven UK blood clot deaths after AstraZeneca vaccine

Health

EPASeven people have died from unusual blood clots after getting the Oxford-AstraZeneca vaccine in the UK, the medicines regulator has confirmed to the BBC. In total, 30 people out of 18 million vaccinated by 24 March had these clots.It is still not clear if they are just a coincidence or a genuine side effect of the vaccine.The Medicines and Healthcare Products Regulatory Agency says the benefits continue to outweigh any risk. However, concern has led to other countries including Germany, France, the Netherlands and Canada to restrict the vaccine's use only to older people. The data released by the MHRA on Friday showed 22 cases of cerebral venous sinus thrombosis (CVST) which is a type of blood clot in the brain. These were accompanied by low levels of platelets, which help form blood cl...

Mar312021 by adminNo Comments

Germany halts use of AstraZeneca COVID-19 vaccine to those under 60

World

March 31 (UPI) -- German health officials restricted the use of AstraZeneca's COVID-19 vaccine to those over the age of 60 due to concerns of rare yet severe cases of blood clots in younger people who had received the shot. Chancellor Angela Merkel and Health Minister Jens Spahn made the announcement during a press conference on Tuesday to halt administering the drug to those under 60 years of age on the recommendations of the country's independent Standing Vaccination Commission. Advertisement Merkel added that those below 60 may still receive the life-saving jab at a doctor's discretion. Concerning the 2.2 million younger Germans who have already received the first shot of the two-dose regimen, Merkel said the STIKO will make a recommendation by the end of April. "The recommendations o...

Mar262021 by adminNo Comments

EU turns up the heat on AstraZeneca – and warns company must honour its vaccine contract

World

EU leaders have told AstraZeneca that it must "catch up" on vaccine deliveries in Europe before it is allowed to export jabs to other countries. Frustration is growing in Brussels over a massive shortfall in the number of jabs that EU countries are receiving - with the continent's vaccination programme lagging behind the UK. At a news conference, European Commission President Ursula von der Leyen said the trading bloc is determined to get its "fair share" of vaccines. She added: "Companies have to honour their contract to the European Union before they export to other regions in the world. This is of course the case with AstraZeneca."I think it is clear that the company has to catch up and honour the contract it has with the EU member states before it can engage again in exporting vaccines...

Mar242021 by adminNo Comments

AstraZeneca denies ‘stockpile’ claims, saying 29m doses in factory are for EU and developing countries

World

AstraZeneca has hit back after claims of a stockpile of 29 million doses of its COVID-19 vaccine at a factory near Rome, saying the jabs are for the EU and developing countries.It follows an inspection of the Catalent plant in Anagni over the weekend by Italian authorities at the request of the European Commission. An official at the French presidency said this week that the destination for those doses "still needs to be clarified," and noted that if the jabs were for export, they could be blocked.The plant is in charge of bottling AstraZeneca vaccines produced at the Halix factory in the Netherlands. Live COVID updates from across the UK and around the world ...

Mar222021 by adminNo Comments

AstraZeneca: US data shows vaccine effective for all ages

Health

LONDON -- AstraZeneca’s COVID-19 vaccine provided strong protection against disease and complete protection against hospitalization and death across all age groups in a late-stage U.S. study, the company announced Monday.AstraZeneca said its experts also identified no safety concerns related to the vaccine, including a rare blood clot that was identified in Europe. Scientists found no increased risk of clots among the more than 20,000 people who got at least one dose of the AstraZeneca shot.Although AstraZeneca's vaccine has been authorized in more than 50 countries, it has not yet been given the green light in the U.S. The U.S. study comprised more than 30,000 volunteers, of whom two-thirds were given the vaccine while the rest got dummy shots.In a statement, AstraZeneca said its COVID-19...